Sale!

SCN5A Gene Cardiomyopathy Dilated Type 1E NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SCN5A Gene Cardiomyopathy Dilated Type 1E NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the SCN5A gene associated with dilated cardiomyopathy type 1E. This comprehensive genetic analysis helps detect inherited heart conditions that can lead to heart failure, arrhythmias, and sudden cardiac death. Using Next-Generation Sequencing (NGS) technology, the test provides precise detection of genetic variants affecting sodium channel function in cardiac cells. Ideal for individuals with family history of cardiomyopathy, unexplained heart symptoms, or those seeking proactive cardiac health screening. Results are typically available within 3-4 weeks from blood or DNA samples. The test is priced at $500 USD with regular pricing at $700 USD, making advanced genetic cardiac screening accessible for comprehensive heart health management.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SCN5A Gene Cardiomyopathy Dilated Type 1E NGS Genetic DNA Test

Comprehensive Introduction to Cardiac Genetic Testing

The SCN5A Gene Cardiomyopathy Dilated Type 1E NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic medicine, offering precise detection of inherited heart conditions that affect millions worldwide. This advanced diagnostic tool specifically targets mutations in the SCN5A gene, which plays a critical role in regulating sodium channels within cardiac muscle cells. When these channels malfunction due to genetic variations, they can lead to dilated cardiomyopathy type 1E—a serious condition characterized by enlarged heart chambers and reduced pumping efficiency.

Early identification of SCN5A gene mutations is paramount for preventing progressive heart damage and sudden cardiac events. Our state-of-the-art NGS technology provides unparalleled accuracy in detecting even the most subtle genetic variations, enabling healthcare providers to implement targeted treatment strategies and preventive measures before irreversible cardiac damage occurs.

What This Advanced Genetic Test Detects

The SCN5A Gene Cardiomyopathy Test employs sophisticated Next-Generation Sequencing methodology to comprehensively analyze the entire SCN5A gene sequence. This comprehensive approach identifies:

  • Pathogenic mutations affecting sodium channel function
  • Genetic variants associated with dilated cardiomyopathy type 1E
  • Inherited patterns of cardiac electrical abnormalities
  • Risk factors for progressive heart muscle enlargement
  • Genetic markers for arrhythmia susceptibility

By examining the complete genetic blueprint of the SCN5A gene, our test provides crucial information about your cardiac health inheritance patterns and potential risk factors that conventional cardiac testing might miss.

Who Should Consider SCN5A Genetic Testing?

Primary Candidates for Testing

This genetic screening is particularly recommended for individuals experiencing:

  • Unexplained shortness of breath during routine activities
  • Persistent fatigue and reduced exercise tolerance
  • Family history of cardiomyopathy or sudden cardiac death
  • Unexplained heart palpitations or irregular heartbeats
  • Swelling in legs, ankles, or abdomen without clear cause
  • Previous diagnosis of enlarged heart chambers
  • History of fainting spells or near-fainting episodes

Proactive Health Screening

Even without current symptoms, individuals with known family history of cardiac conditions should consider this test as part of comprehensive preventive healthcare. Early detection enables lifestyle modifications and medical interventions that can significantly improve long-term cardiovascular outcomes.

Significant Benefits of Genetic Cardiac Screening

Undergoing the SCN5A Gene Cardiomyopathy Test provides numerous advantages for cardiac health management:

  • Early Risk Identification: Detect genetic predispositions before symptom onset
  • Personalized Treatment Planning: Enable targeted therapies based on genetic profile
  • Family Health Awareness: Provide crucial information for relatives’ health decisions
  • Preventive Intervention: Implement lifestyle changes to delay disease progression
  • Peace of Mind: Reduce uncertainty about inherited cardiac risks
  • Comprehensive Health Strategy: Integrate genetic insights into overall wellness planning

Understanding Your Genetic Test Results

Result Interpretation Framework

Your SCN5A genetic test results will fall into one of several categories, each with specific implications for your cardiac health management:

  • Positive Result: Indicates presence of known pathogenic mutation requiring cardiology consultation and ongoing monitoring
  • Negative Result: Suggests absence of tested SCN5A mutations, though continued cardiac health vigilance remains important
  • Variant of Uncertain Significance: Identifies genetic changes requiring further research and periodic re-evaluation
  • Carrier Status: May indicate potential for passing genetic variations to offspring

Post-Test Guidance

All results are accompanied by comprehensive genetic counseling to ensure complete understanding of implications for your health and family. Our genetic specialists provide personalized recommendations for:

  • Cardiac monitoring frequency and methods
  • Lifestyle modifications to support heart health
  • Medication considerations if indicated
  • Family screening recommendations
  • Long-term health management strategies

Test Pricing and Service Details

Service Description Price (USD)
Discount Price $500
Regular Price $700

Additional Service Information

  • Turnaround Time: 3 to 4 Weeks
  • Sample Types Accepted: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Pre-Test Requirements: Clinical History and Genetic Counseling Session
  • Specialty: Cardiology and Genetics
  • Testing Method: Advanced NGS Technology
  • Disease Focus: Cardiovascular Disorders

Nationwide Accessibility and Booking

General Genetics Corporation maintains comprehensive testing facilities across the United States, ensuring convenient access to advanced cardiac genetic screening. Our network includes specialized centers in:

  • New York Metropolitan Area
  • Los Angeles and Southern California
  • Chicago and Midwest Regions
  • Houston and Texas Gulf Coast
  • Phoenix and Southwest Territories
  • All major metropolitan areas nationwide

Take Control of Your Cardiac Health Today

Don’t leave your heart health to chance. The SCN5A Gene Cardiomyopathy Dilated Type 1E NGS Genetic DNA Test provides the scientific clarity needed for informed health decisions. Our experienced genetic counselors and cardiac specialists are ready to guide you through every step of the testing process.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic counseling session and book your comprehensive cardiac genetic screening. Take the first step toward understanding your inherited cardiac risks and implementing proactive health strategies for yourself and your family.

Early detection through advanced genetic testing can make the critical difference in managing cardiac health effectively. Contact us today to begin your journey toward comprehensive cardiovascular wellness.